The opioid antagonist naltrexone improves murine inflammatory bowel disease. [electronic resource]
Producer: 20080812Description: 179-87 p. digitalISSN:- 1547-6901
- Animals
- Biomarkers
- Dextran Sulfate -- toxicity
- Disease Models, Animal
- Gene Expression Regulation -- drug effects
- Humans
- Inflammation Mediators -- immunology
- Inflammatory Bowel Diseases -- chemically induced
- Interleukin-12 -- immunology
- Interleukin-6 -- immunology
- Male
- Mice
- Naltrexone -- pharmacology
- Narcotic Antagonists -- pharmacology
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.